It focused on the longitudinal changes in serum levels of specific factors like IL-6, IL-8, VEGF, HGF, and GRO-α in 30 patients undergoing chemoradiation therapy for stage III/IV oropharyngeal squamous cell carcinomas. This evidence concerns the gene VEGFA and oropharynx squamous cell carcinoma.